As approximately 63% of the PDM patients evaluated produced high levels of IL-6, it is possible that this inflammatory mediator may be a relevant factor in driving patients with prediabetes to develop severe COVID-19 (9–11, 13, 14). The gene discussed is IL6; the disease is prediabetes syndrome.